Corporate Banner
Satellite Banner
Informatics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Observing Behavior of Single Molecules in Real Time

Published: Monday, March 17, 2014
Last Updated: Monday, March 17, 2014
Bookmark and Share
New technique developed by Stanford scientists allows observation of single molecules of protein or DNA as they bind with other molecules.

Nearly every biological or chemical reaction that makes life possible involves single molecules interacting in the watery solution that sloshes in and around cells.

Now, a Stanford chemistry professor and his graduate student have developed a technique for observing these processes as they happen in real time.

W.E. Moerner, a professor of chemistry, specializes in single molecule fluorescence, a field that involves studying how biomolecules – such as DNA and enzymes – work in cells to carry out the processes that are critical to life. The new advance describes how Moerner and his graduate student, Quan Wang, modified an ABEL (Anti-Brownian ELectrokinetic) trap, a machine invented in Moerner's lab that uses electric fields to manipulate individual small molecules from the light they emit, to isolate a single strand of DNA and observe how it binds to other DNA, in aqueous solution.

The work is detailed in the journal Nature Methods.

Getting this process started takes a little bit of luck, Wang said, as they must wait until a single molecule happens to be in the vicinity of the trap. This all happens at an incredibly tiny scale. The trap covers about a square centimeter, but the molecules are just 1 nanometer long. (For perspective, that's trapping a single grain of pollen on a football field, and then, without ever touching it, studying its behavior and characteristics.)

Once a lone molecule has entered the trap, its motion comes under continuous surveillance. Although the molecule doesn't want to sit still, every time it attempts to escape, the ABEL trap automatically applies electric fields to push it back.

Using physical analysis and computational tricks from machine learning, Wang developed an algorithm to convert the observed single-molecule motions inside the trap into information about the molecule's size and electric charge. From this, the researchers can determine whether the target molecule has interacted with another molecule.

In the case of DNA, if it begins to hybridize – that is, if it begins to bond to a complementary strand of DNA – the readings from the trap will show that the trapped DNA has an increase in both size and charge. When the process reverses a few instants later – that is, when the DNA melts and its complementary strand falls off – the trapped molecule's size and charge change back correspondingly.

"It is really quite amazing to be able to trap a single short piece of single-stranded DNA, to watch it for many seconds and directly observe a partner strand bind and unbind," Moerner said. "This is really an essential process."

The researchers conducted similar tests using proteins, and Wang said that the technology in its current state can easily be applied to many different types of molecules to study other binding processes.

"We've done the proof of concept for the method, and soon we want to apply it to two very specific problems and get some science out of it," said Wang, who is a graduate student in electrical engineering.

The first involves drug design. Drugs target diseases by binding to receptor molecules on cells, and the drug's effectiveness often depends on how well and for how long it binds to its receptor. By gauging the size and total charge of the molecules as they form a complex, the trap can directly measure how long it takes for the drug to find its receptor and how long the complex stays together. This information could guide scientists toward designing drugs that better match their target receptor.

Another application is to study the role protein aggregation plays in various diseases. As people age, proteins can become "sticky" and accumulate, a hallmark of several diseases, including Huntington's. The trap provides a direct way to study the size distribution of these proteins and how they aggregate; understanding this effect could lead to treatments that inhibit it.

Other students and postdoctoral scholars in Moerner's group are working to make the trap respond even more quickly, to perform more optimally in other situations, or to study different properties of single molecules. Moerner said that the interdisciplinary makeup of his group (including him; he holds a degree in electrical engineering as well as in chemistry) is critical for understanding all the different facets of this work, and then for smart implementation of it.

"We use light to probe molecules – that's physics and chemistry," Moerner said. "And we apply it to biology and biomedical systems. But at the core is precise measurement, extracting as much information as possible from a single object, and that can be done with concepts from electrical engineering.

"It's a natural thing at Stanford for students in one department to do thesis research in another. It's one of the wonderful aspects at Stanford, and it can lead to wonderful work such as this."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Viral Infections Leave a Signature on the Immune System
A test that queries the body’s own cells can distinguish a viral infection from a bacterial infection and could help doctors know when to use antibiotics.
Thursday, December 17, 2015
Big Data Helps Pinpoint Possible New Stent Drug
Replacing the current drug used to coat artery-opening stents with a drug more targeted to the actual cause of stent disease could reduce blood clots and heart attacks.
Wednesday, November 19, 2014
Key Mechanism in Energy and Information Storage
Observing how hydrogen is absorbed into individual palladium nanocubes, Stanford materials scientists have detailed a key step in storing energy and information in nanomaterials.
Monday, September 15, 2014
Stanford Bioengineers Create Circuit Board Modeled on the Human Brain
Development offers greater possibilities for advances in robotics and a new way of understanding the brain.
Wednesday, April 30, 2014
Stanford Launches New Center to Advance 'Information Age of Genomics'
With a new research center, Stanford scientists from across campus will join a new "information age of genomics." The goal is nothing short of improving human well-being.
Tuesday, December 04, 2012
Scientific News
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Applying Deep Learning to Drug Discovery
Researchers train deep neural networks to predict the therapeutic use of large number of multiple drugs using gene expression data obtained from high-throughput experiments on human cell lines.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Gene Expression Controls Revealed
Researchers have modelled every atom in a key part of the process for switching on genes, revealing a whole new area for potential drug targets.
Making Genetic Data Easier to Search
Scripps team streamlines biomedical research by making genetic data easier to search.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
New Database for Sharing MS Clinical Trial Data
A new database containing nearly 2500 patient records from the placebo arms of nine multiple sclerosis (MS) clinical trials is now available for research by qualified investigators.
‘Precision Prevention’ for Colorectal Cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!